Metabolic syndrome is an independent risk factor for synchronous colorectal neoplasm in patients with gastric neoplasm

Journal of Gastroenterology and Hepatology (Australia)

Volumn 27, Issue 9, 2012, Pages 1490-1497

  Park, Wan ^a   Lee, Hyuk ^a   Kim, Eun Hye ^a   Yoon, Ji Young ^a   Park, Jun Chul ^a   Shin, Sung Kwan ^a   Lee, Sang Kil ^a   Lee, Yong Chan ^a   Kim, Won Ho ^a   Noh, Sung Hoon ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Colonoscopy; Colorectal neoplasm; Gastric neoplasm; Metabolic syndrome; Screening

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER SCREENING; COLONOSCOPY; COLORECTAL ADENOMA; COLORECTAL CANCER; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; STOMACH CANCER; SYNCHRONOUS COLORECTAL NEOPLASM;

EID: 84865399919     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2012.07128.x     Document Type: Article

References (28)

1. Busuttil RA, Boussioutas A. Intestinal metaplasia: a premalignant lesion involved in gastric carcinogenesis. J. Gastroenterol. Hepatol. 2009; 24: 193-201.
2. Yang MH, Son HJ, Lee JH etal. Do we need colonoscopy in patients with gastric adenomas? The risk of colorectal adenoma in patients with gastric adenomas. Gastrointest. Endosc. 2010; 71: 774-81.
3. Kim HO, Hwang SI, Yoo CH, Kim H. Preoperative colonoscopy for patients with gastric adenocarcinoma. J. Gastroenterol. Hepatol. 2009; 24: 1740-4.
4. Jemal A, Siegel R, Ward E etal. Cancer statistics, 2008. CA Cancer J. Clin. 2008; 58: 71-96.
5. Ha TK, An JY, Youn HG, Noh JH, Sohn TS, Kim S. Surgical outcome of synchronous second primary cancer in patients with gastric cancer. Yonsei Med. J. 2007; 48: 981-7.
6. Grundy SM, Brewer HB Jr, Cleeman JI etal. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004; 109: 433-8.
7. Chiu HM, Lin JT, Shun CT etal. Association of metabolic syndrome with proximal and synchronous colorectal neoplasm. Clin. Gastroenterol. Hepatol. 2007; 5: 221-9, quiz 141.
8. Kang HW, Kim D, Kim HJ etal. Visceral obesity and insulin resistance as risk factors for colorectal adenoma: a cross-sectional, case-control study. Am. J. Gastroenterol. 2010; 105: 178-87.
9. Kim JH, Lim YJ, Kim YH etal. Is metabolic syndrome a risk factor for colorectal adenoma? Cancer Epidemiol. Biomarkers Prev. 2007; 16: 1543-6.
10. Liu CS, Hsu HS, Li CI etal. Central obesity and atherogenic dyslipidemia in metabolic syndrome are associated with increased risk for colorectal adenoma in a Chinese population. BMC Gastroenterol. 2010; 10: 51-7.
11. Yang P, Zhou Y, Chen B etal. Overweight, obesity and gastric cancer risk: results from a meta-analysis of cohort studies. Eur. J. Cancer 2009; 45: 2867-73.
12. Corley DA, Kubo A, Zhao W. Abdominal obesity and the risk of esophageal and gastric cardia carcinomas. Cancer Epidemiol. Biomarkers Prev. 2008; 17: 352-8.
13. Engel LS, Chow WH, Vaughan TL etal. Population attributable risks of esophageal and gastric cancers. J. Natl. Cancer Inst. 2003; 95: 1404-13.
14. Tseng CH. Diabetes conveys a higher risk of gastric cancer mortality despite an age-standardised decreasing trend in the general population in Taiwan. Gut 2011; 60: 774-9.
15. Levine JS, Ahnen DJ. Clinical practice. Adenomatous polyps of the colon. N. Engl. J. Med. 2006; 355: 2551-7.
16. Expert Panel on Detection E, Treatment of High Blood Cholesterol in A. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-97.
17. Tan CE, Ma S, Wai D, Chew SK, Tai ES. Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians? Diabetes Care 2004; 27: 1182-6.
18. Park DI, Park SH, Yoo TW etal. The prevalence of colorectal neoplasia in patients with gastric cancer: a Korean Association for the Study of Intestinal Disease (KASID) Study. J. Clin. Gastroenterol. 2010; 44: 102-5.
19. Joo MK, Park JJ, Lee WW etal. Differences in the prevalence of colorectal polyps in patients undergoing endoscopic removal of gastric adenoma or early gastric cancer and in healthy individuals. Endoscopy 2010; 42: 114-20.
20. Kubo A, Corley DA. Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis. Cancer Epidemiol. Biomarkers Prev. 2006; 15: 872-8.
21. Wang YY, Lin SY, Lai WA, Liu PH, Sheu WH. Association between adenomas of rectosigmoid colon and metabolic syndrome features in a Chinese population. J. Gastroenterol. Hepatol. 2005; 20: 1410-15.
22. Lee GE, Park HS, Yun KE etal. Association between BMI and metabolic syndrome and adenomatous colonic polyps in Korean men. Obesity (Silver Spring) 2008; 16: 1434-9.
23. Aleksandrova K, Boeing H, Jenab M etal. Metabolic syndrome and risks of colon and rectal cancer: the European prospective investigation into cancer and nutrition study. Cancer Prev. Res. (Phila.) 2011; 4: 1873-83.
24. Flood A, Mai V, Pfeiffer R etal. Elevated serum concentrations of insulin and glucose increase risk of recurrent colorectal adenomas. Gastroenterology 2007; 133: 1423-9.
25. Jacobs ET, Martinez ME, Alberts DS etal. Association between body size and colorectal adenoma recurrence. Clin. Gastroenterol. Hepatol. 2007; 5: 982-90.
26. Matsuo K, Mizoue T, Tanaka K etal. Association between body mass index and the colorectal cancer risk in Japan: pooled analysis of population-based cohort studies in Japan. Ann. Oncol. 2012; 23: 479-490.
27. Hassan C, Pickhardt PJ, Marmo R, Choi JR. Impact of lifestyle factors on colorectal polyp detection in the screening setting. Dis. Colon Rectum 2010; 53: 1328-33.
28. Giovannucci E. Obesity, gender, and colon cancer. Gut 2002; 51: 147.